ipf-eu-patient-logo

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, unpredictable and ultimately fatal lung disease
The European IPF Patient Charter calls for greater awareness of IPF and for better access to care in European countries

SIGN THE CHARTER

The European IPF Patient Charter calls for greater awareness of IPF and for better access to care in European countries. The Charter lays down recommendations that, if adopted, would ensure improvements in IPF patients’ quality of life, whilst supporting efforts to find a cure.

currently, between 80,000 and 111,000 people are living with Idiopathic Pulmonary Fibrosis in Europe. This fatal condition has been around for decades, yet there is no cure and only limited treatment available. IPF often develops rapidly and many patients are given a survival time of just two to five years. Each year around 35,000 people in Europe are newly diagnosed with IPF, with this number likely to increase in the future.

European IPF Patient Organisations call for patients and their families to have consistent and fair rights to:

1) Early and accurate diagnosis
2) Equal access to care
3) A holistic approach to standardise IPF management
4) Comprehensive and high quality information about the condition
5) Better access to palliative care and end-of-life care

Read the Charter

sign-up

SIGN THE CHARTER NOW!

Name (required)

Surname (required)

Nationality (required)

Country (required)

Your Email

I've read and agree with the terms of use and the privacy policy.

We hate spammers, so please prove you are NOT a robot by solving this:



35,000

Our Goal: 35,000 signatures

16,902

Up to Now

Last update: 02/01/2017

Members

Written Declaration 26 on IPF is adopted!

Latest From The Blog

Forthcoming review of the Italian National Plan for Rare Diseases

ITALY, April 2016 – After the success of the presentation of the European IPF Patient Charter to the national political decision-makers, we have achieved an important result: the motion presented by Mr. Pierpaolo Vargiu (photo), Member of the Chamber, has been approved unanimously in the Italian National Low Chamber. This [...]

IPF patients and experts at Italian Parliament

Rome, 2016 March 1st. A key event promoted by AMA Fuori Dal Buio has taken place at the Chamber of Deputies – Sala del Refettorio: “Idiopathic Pulmonary Fibrosis patients’ right to be diagnosed and to access treatment. The European IPF Charter and the importance to recognize IPF as [...]

Patient Groups join together to form a Federation dedicated to IPF

Patient Groups join together to form a Federation dedicated to Idiopathic Pulmonary Fibrosis & Related Disorders Brussels, Belgium, 22 February 2016 Patient groups from nine European countries have come together to establish the European Idiopathic Pulmonary Fibrosis & Related Disorders Federation (EU-IPFF) in order to defend the interests of European patients with [...]

The IPF Patient Charter in Rome

March, 1st 2016, the IPF Patient Charter in Rome. “Idiopathic Pulmonary Fibrosis patients’ right to be diagnosed and to access treatment”   On March, 1st 2016, a key event promoted by AMA Fuori Dal Buio will take place, at 10.30 a.m. at the Chamber of Deputies – Sala del Refettorio [...]

ERS Journal publishes an article on the European IPF Patient Charter

Healthcare professionals and IPF Patient organisations work hand-in-hand to shed light on the inequalities and unmet needs in IPF care across Europe On 19 November the European Respiratory Journal has published an article entitled “European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers” which outlines [...]

Giving a future to patients living with rare pulmonary diseases

IPF Groups organise the second European Parliament Roundtable entitled “Breath of Hope: Giving a future to patients living with rare pulmonary diseases” on 15 September 2015. Following the formal launch of the European Idiopathic Pulmonary Fibrosis (IPF) Patient Charter in the European Parliament in September 2014, national IPF patient associations [...]